Madeline F. Long

Also affiliated with Health Advances (United States), Center for Discovery

Biochemistry, Genetics and Molecular BiologyNeuroscienceComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes – Part 2”.

Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes – Part 2

Bioorganic & Medicinal Chemistry Letters(2021)10.1016/j.bmcl.2021.128416

N/A

0DataRank · unranked

8 citations

Rory A. Capstick, Paul K. Spearing, Julie L. Engers, Alison R. Gregro, Sean R. Bollinger +11 more

Discovery of VU6007496: Challenges in the Development of an M1 Positive Allosteric Modulator Backup Candidate

ACS Chemical Neuroscience(2024)10.1021/acschemneuro.4c00508

N/A

0DataRank · unranked

8 citations

Katrina A. Bollinger, Rory A. Capstick, Madeline F. Long, Aaron M. Bender, Jonathan W. Dickerson +14 more

Discovery of VU6008677: A Structurally Distinct Tricyclic M4 Positive Allosteric Modulator with Improved CYP450 Profile

ACS Medicinal Chemistry Letters(2024)10.1021/acsmedchemlett.4c00249

N/A

0DataRank · unranked

6 citations

Sean R. Bollinger, Julie L. Engers, Madeline F. Long, Sichen Chang, Vincent B. Luscombe +9 more